Biomedical subjects

N Okimoto

Publications and source records attributed to N Okimoto.

87 records · Page 5Linked to original sources

PubMed1990

[The present situation and the future prospect of pulmonary function test].

We described 6 points of the present situation and the future prospect of pulmonary function tests. The pulmonary function test using different equipment on the same subject gave different results. The results of the pulmonary function test were affected by the subject's efforts. There were no standard prediction equations. Normal subjects and patients with respiratory disease reached the limit of exercise tolerance when the ratio of tidal volume during exercise to vital capacity (VT/VC ratio) approached 50%. Respiratory rehabilitation was evaluated by pulmonary function tests. The development of equipment allowing measurement by subject's quiet breathing is awaited.

Exercise Test↗

PubMed1989

Urinastatin (Kunitz-type proteinase inhibitor) reducing cisplatin nephrotoxicity.

The authors investigated the reductive effects of a Kunitz-type proteinase inhibitor, urinastatin, on the nephrotoxicity seen in lung cancer patients treated with cisplatin by measuring N-acetyl-beta-D-glucosaminidase (NAG) activity and beta 2-microglobulin (BMG) content in 24 hour urine, creatinine clearance, blood urea nitrogen (BUN), serum creatinine, uric acid, and BMG as factors of nephrotoxicity. In control patients treated with anticancer drugs containing cisplatin but no supplemental urinastatin, the 24 hour urine NAG and BMG levels increased more than three-fold over the pretreatment levels, 3 days after anticancer therapy, respectively. Creatinine clearance significantly decreased and levels of BUN, serum uric acid, and BMG in control patients significantly increased over the corresponding pretreatment levels, 3 days after anticancer therapy. However, supplemental urinastatin reduced abnormalities in levels of all these factors 3 days after therapy. These results suggest that supplemental urinastatin protects from cisplatin-induced nephrotoxicity, especially proximal tubular damage.

Acetylglucosaminidase↗

PubMed1989

[M. kansasii lung infection occurring in a compromised host with idiopathic pulmonary fibrosis].

A 61-year-old man was admitted to our hospital because of persisting cough, sputum and shortness of breath for four months. Brushing specimens and BALF bronchoscopically obtained revealed acid-fast bacilli and TBLB showed pathological findings consistent with interstitial pneumonia. Based on these results, clinical symptoms, chest roentgenograms on admission and identification of M. kansasii, a diagnosis of M. kansasii lung infection occurred in idiopathic pulmonary fibrosis was made. The patient's symptoms consistent with M. kansasii lung infection and his sputum became negative 6 weeks after antituberculosis chemotherapy with INH, SM and RFP. Because of an increasing dyspnea due to pulmonary fibrosis, however, the patient received oxygen therapy. This case suggested an increasing tendency of compromised hosts associated with M. kansasii lung infection.

Humans↗

PubMed1989

[A case of pneumonitis due to sho-saiko-to].

We reported a case of pneumonitis due to Sho-saiko-to. A 71-year-old woman was admitted to our hospital because of pneumonia. She complained of dry cough, pyrexia and severe dyspnea. Fine crepitation was heard on physical examination of the chest and a chest X-ray film revealed diffuse reticulo-nodular shadow in both lung fields. We suspected summer-type hypersensitivity pneumonitis and followed her up, however her condition deteriorated. Under a suspicion of drug-induced pneumonitis, all drugs were stopped and she was given prednisolone. Consequently her complaints, laboratory data and chest X-ray findings markedly improved. Microscopic examination of a transbronchial lung biopsy specimens showed interstitial pneumonitis. The results of a lymphocyte stimulation test were positive for sho-saiko-to. She gave informed consent after receiving an explanation of the challenge test. She was tested with 2.5 g sho-saiko-to twice and developed high fever and dyspnea with hypoxia, while the chest X-ray film also revealed diffuse infiltrative shadows similar that on admission. Based on these findings, we diagnosed this case as pneumonitis due to sho-saiko-to. To our knowledge, there has been no previous case of pulmonary hypersensitivity due to sho-saiko-to reported in the world.

Aged↗

PubMed1989

[Investigation of severe tuberculous pneumonia associated with irreversible exacerbation after intensive antitubercular chemotherapy--with regard to the etiology of initial reversible roentgenographic progression].

We reported 3 cases of severe tuberculous pneumonia associated with irreversible exacerbation and sequential death appeared after each intensive antitubercular chemotherapy containing INH, RFP, EB and SM. Acute tuberculous pneumonia probably represents an exudative hypersensitivity reaction to tuberculoprotein, rather than actual inflammation caused by the Mycobacterium tuberculosis organism. Mechanisms of the reversible roentgenographic progression are considered to be also similar to those of acute tuberculous pneumonia regarding the involvement of an exudative hypersensitivity reaction to tuberculoprotein. Our cases indicate that the involvement of reversible roentgenographic progression in patients with severe tuberculous pneumonia may result in the development of acute respiratory failure or adult respiratory distress syndrome (ARDS), resulting from the acceleration of exudative hypersensitivity reactions by the intensive antitubercular chemotherapy. In the present report, relationships between tuberculous pneumonia, reversible roentgenographic progression and the appearance of acute respiratory failure (or ARDS) were discussed. Furthermore, the use of steroids is discussed.

Acute Disease↗

PubMed1988